Md. biotech firm nears market with two drugs that could be safer for cancer patients
The CEO said his company aims to make cancer therapies that "eliminate the collateral damage" caused by other drugs on the market.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Morgan Eichensehr Source Type: news
More News: American Health | Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Health Management